Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 101439
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.101439
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.101439
Table 4 Comparison of adverse reactions between the two groups, n (%)
| Adverse reactions | Control group (n = 50) | Multimodal group (n = 50) | χ2 | P value |
| PONV | 15 (30) | 6 (12) | 4.882 | 0.027 |
| Constipation | 7 (14) | 4 (8) | 0.919 | 0.338 |
| Dysuria | 6 (12) | 4 (8) | 0.444 | 0.505 |
| Hypersomnia | 10 (20) | 5 (10) | 1.961 | 0.161 |
| Total | 33 (66) | 19 (38) | 10.306 | 0.001 |
- Citation: Yan J, An R, Wang JJ, Wang M, Zhao Q, Zhao S, Xu J. Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(4): 101439
- URL: https://www.wjgnet.com/1948-9366/full/v17/i4/101439.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i4.101439